Guru Ownership Trend
Guru Analysis for Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.22 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $885,700.38 net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 180.6%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 23.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Keros Therapeutics, Inc. (KROS)
Major holders include Renaissance Technologies (RenTech) ($5.01 M), Cliff Asness ($4.49 M), Steven Cohen ($1.2 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 997,067 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $885,700.38, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited KROS. The total reported sell value was $2.38 M.
Yes, 0 managers opened new positions in KROS, and 2 increased their existing holdings. The total reported buy value was $3.27 M.